Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of MRW, please enable cookies in your browser

We'll assume we have your consent to use cookies, so you won't need to log in each time you visit our site.
Learn more

Andusia expands into clinical waste due to 'lack of UK capacity'

The UK’s clinical waste incinerators are “ageing” and in need of replacement, according to hazardous waste manager at the newly formed Andusia Hazchem Treatment company. 

Refuse-derived fuel (RDF) specialist Andusia recently set up a clinical waste trading arm. It has joined forces with developer Clinitek to secure a five-year contract to supply a new facility in Malvern, Worcestershire, in order to deal with around 8,000 tonnes of clinical waste per year.

The facility will replace an existing retired plant. Andusia will supply hazardous and clinical waste for high temperature treatment under a five-year deal from January 2020. 

Andusia Hazchem Treatment has two more contracts with Clinitek and hopes to secure one for a possible fourth facility.

All facilities are at various stages of development. A second site in Ayrshire, Scotland, is expected to take up to 15,000 tonnes a year.

Andusia director, Mark Terrell, said “Moving into the hazardous waste market means we can now offer an extensive RDF, solid recovered fuel and hazardous waste solution.”

He added that there was, “a real lack of UK facilities to deal with hazardous waste”.

In January Andusia Hazchem Treatment took on Fraser Cutting as its new hazardous waste manager, who was formerly at the collapsed Healthcare Environmental Services.

Cutting said: “There is definitely a need for this [new clinical waste incinerators] within the industry.

“The facilities in the UK are old – just look down South at the number of incinerators that have gone down in unison. They were very good in their day but are ageing and certainly can’t be relied on en mass for the UK going forward.”

Clinitek said the plant was the “first of its kind to be developed in over ten years”. A spokesperson added: “We are really proud of this new venture working alongside Andusia and are excited for what is to come.”

The Malvern plant is being funded by UK infrastructure investor, Equitix.

An Equitix spokesperson said: “This new project marks the latest addition to our growing waste portfolio. This is a sector that we see huge opportunities in and are very excited to be working with our partners in developing this top-quality, high-impact facility.”

HES was stripped of its NHS contracts after it was found to be stockpiling clinical waste and the company folded in December last year.

There have been reports of continued stockpiling following the company’s collapse.

Cutting said: “I look forward to the film coming out in 20 years time to find out what’s gone on here.”

Andusia is now trading under three separate companies; Andusia Recovered Fuels representing the waste export business, Andusia Hazchem Treatment representing the hazardous waste treatment arm and Andusia Resource Recovery representing the UK RDF business.



Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.